Skip to content Skip to footer

Find an expert

1 - 8 of 8 results

Dr Will Anderson

Industry Research Fellow
Australian Institute for Bioengineering and Nanotechnology
Availability:
Not available for supervision

Dr Will Anderson is a Research Fellow at The University of Queensland, specialising in molecular diagnostics, nanoparticle characterisation, and translational device development. His current work focuses on developing diagnostics for single molecule quantitation and low-cost, accessible technologies for nucleic acid analysis.

Dr Anderson has over 15 years of R&D experience spanning academia and industry, with expertise in:

  • Nanopore sensing and nanoparticle analysis

  • Nucleic acid extraction and quantification

  • Diagnostic device prototyping and point-of-care platforms with a focus on fluorescence-based detection

  • Research translation, IP strategy, and regulatory frameworks

Dr Anderson’s work bridges fundamental research and real-world application, with a strong focus on enabling diagnostic innovation through mechatronics, assay development, and collaborative industry engagement.

Will Anderson
Will Anderson

Dr Selvakumar Edwardraja

Adjunct Senior Fellow
Australian Institute for Bioengineering and Nanotechnology
Availability:
Available for supervision
Selvakumar Edwardraja
Selvakumar Edwardraja

Dr Jocelyn Hume

Postdoctoral Research Fellow
Frazer Institute
Faculty of Health, Medicine and Behavioural Sciences
Availability:
Not available for supervision
Jocelyn Hume

Dr Kevin M. Koo

Affiliate of Australian Institute for Bioengineering and Nanotechnology
Australian Institute for Bioengineering and Nanotechnology
NHMRC Emerging Leadership Fellow
Frazer Institute
Faculty of Health, Medicine and Behavioural Sciences
Availability:
Available for supervision
Media expert

Dr Kevin M. Koo is currently a National Health and Medical Research Council (NHMRC) Investigator Fellow and Prostate Cancer Foundation of Australia (PCFA) Future Leader Fellow at The University of Queensland (UQ). Dr Koo was awarded his PhD (Dean’s Award for Outstanding Thesis & Springer Thesis Prize) from the Australian Institute for Bioengineering & Nanotechnology (AIBN), UQ in 2018.

Post-PhD, he begun a productive postdoctoral career with dual industry/academia appointments: as the Head of Assay Development/Lab Director in XING Technologies Pty Ltd (a Brisbane-based biotech start-up) to undertake product development projects for commercialization of disease in vitro diagnostics, and as an Honorary Fellow/Principal Research Scientist at UQ Centre for Clinical Research (UQCCR) to continue his academic research in precision cancer nanodiagnostics. His research skills and experiences are honed through dedicated career time spent in both academic research and regulated industry environments.

Dr Koo's research encompasses multi-disciplinary fields of molecular biomarker and nanobiosensor development, translation, and commercialization for precision disease management applications. Presently, he is working on the design and development of integrated multi-bioanalyte sensing technologies to resolve the various challenges around holistic disease pathway understanding and clinical biomarker profiling.

Dr Koo's research endeavours have been recognized by a Metrohm Australia-New Zealand Young Chemist Award (2018), Australian Institute of Policy & Science (AIPS) Queensland Young Tall Poppy Science Award (2023) and UQ Faculty of Medicine "Rising Star of the Year" Excellence Award (2024).

Teaching

UQ School of Chemistry and Molecular Biosciences (SCMB)

BIOT7018 Biologics: Course Coordinator 2025-Present

BIOC7001 Advanced Molecular Biology Laboratory: Guest Lecturer 2024-Present

BIOC6001 Introduction to Molecular Biology Laboratory: Guest Lecturer 2024

Kevin M. Koo
Kevin M. Koo

Associate Professor Arutha Kulasinghe

Principal Research Fellow and Brazil Family Chair in Spatial Medicine'
Frazer Institute
Faculty of Health, Medicine and Behavioural Sciences
Availability:
Available for supervision
Media expert

Associate Professor Arutha Kulasinghe leads the Clinical-oMx Lab at the Frazer Institute, University of Queensland, is the inaugural Founding Scientific Director of the Queensland Spatial Biology Centre (QSBC) at the Wesley Research Institute, and holds the Inaugural Brazil Family Chair in Spatial Medicine. A/Prof Kulasinghe has pioneered spatial transcriptomics, proteomics, and interactomics in the Asia-Pacific region, contributing to world-first studies in lung cancer, head and neck cancer, and tissue atlasing studies of infectious diseases across pandemics. His research aims to understand the underlying pathobiology by using an integrative multi-omics approach. A/Prof Kulasinghe has authored over 120 peer-reviewed publications, including in The Lancet Microbe, Journal of Clinical Oncology and Nature Genetics. He is the recipient of the Cure Cancer "Researcher of the Year (2023)," named in the "Top Innovators Award (2024)" by the Australian, Research Australia UNSW Frontiers Award (2026), and InDaily Queensland "40 under 40" (2026) by Solstice Media. He has also been recognised on The Courier-Mail's Queensland Power Lists for Technology and Medicine, named among the scientists and CEOs shaping Queensland's technology future, and among the state's most influential figures in health. A/Prof Kulasinghe is supported by the MRFF, NHMRC, US DoD, Cancer Australia, Cure Cancer, pharma, and numerous hospital and philanthropic organisations.

Arutha Kulasinghe
Arutha Kulasinghe

Dr Mostafa Kamal Masud

Affiliate of Centre for Extracellular Vesicle Nanomedicine
Centre for Extracellular Vesicle Nanomedicine
Faculty of Health, Medicine and Behavioural Sciences
Research Fellow
Australian Institute for Bioengineering and Nanotechnology
Availability:
Available for supervision
Media expert

Dr Mostafa Kamal Masud is a Research Fellow at the Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland (UQ). His research focuses on developing advanced nanomaterials and innovative nanotechnology-based platforms for biomedical diagnostics, particularly the early detection and monitoring of ovarian cancer. His interdisciplinary research integrates nanotechnology, nanoarchitectonics, mesoporous materials, biosensing, surface-enhanced Raman spectroscopy (SERS), electrochemistry and microfluidics to develop sensitive, rapid and accessible diagnostic technologies. A major focus is the analysis of extracellular vesicles (exosomes) and their associated microRNAs as emerging biomarkers for cancer detection and treatment monitoring.

His broader research interests include:

  • Design and fabrication of mesoporous metallic and metal oxide nanomaterials.

  • Plasmonic nanostructures and SERS-based molecular detection.

  • Electrochemical and optical biosensors for disease diagnostics.

  • Microfluidic platforms and integrated lab-on-a-chip technologies.

  • Extracellular vesicle isolation, characterisation and biomarker profiling.

  • Translational nanomedicine and point-of-care diagnostic technologies.

Dr Masud has published extensively in leading international journals, including Advanced Science, Science Advances, ACS Nano, Small, Chemical Science, Chemical Society Reviews, Advanced Healthcare Materials, Biosensors and Bioelectronics, Analytical Chemistry, Lab on a Chip, Nanoscale, etc. His research has attracted competitive funding, including a Cancer Council Queensland Next Generation Cancer Research Fellowship and an Australian Research Council Discovery Early Career Researcher Award. He actively collaborates with researchers across materials science, engineering, biomedical science and clinical research. His long-term goal is to translate fundamental advances in nanotechnology into practical diagnostic solutions that improve healthcare outcomes.

Mostafa Kamal Masud
Mostafa Kamal Masud

Dr Quan Nguyen

Affiliate of Centre for Motor Neuron Disease Research
Centre for Motor Neuron Disease Research
Faculty of Health, Medicine and Behavioural Sciences
Affiliate of Centre for Population and Disease Genomics
Centre for Population and Disease Genomics
Institute for Molecular Bioscience
Senior Research Fellow & Group Leader
Institute for Molecular Bioscience
Availability:
Available for supervision
Media expert

Dr Quan Nguyen is a Group Leader at the Institute for Molecular Bioscience (IMB), The University of Queensland, where he leads the Genomics and Machine Learning (GML) Laboratory. His research focuses on understanding pathological processes within tissues to identify biomarkers for early diagnosis, patient stratification, and prediction of treatment response. His work integrates statistical machine learning techniques with advanced genomic technologies, combining single-cell and spatiotemporal sequencing data with tissue imaging to uncover causal links between genotypes and phenotypes across biological scales, from single cell, to tissue microenvironment, organ, multi-organ and population level. By studying cell-cell interactions, his research also contributes to the discovery of novel drug targets and improved understanding of drug mechanisms and toxicity. The GML Laboratory also develops spatiotemporal experimental platforms for large-scale biomarker profiling and validation in preclinical models and patient cohorts.

Dr Nguyen completed a PhD in Bioengineering at the University of Queensland in 2013, postdoctoral training in Bioinformatics at RIKEN institute in Japan in 2015, a CSIRO Office of Chief Executive (OCE) Research Fellowship in 2016, an IMB Fellow in 2018, an Australian Research Council DECRA fellowship, 2019-2021), and is a National Health and Medical Research Council Leadership Fellow (EL2 2022-2026 and L1 2027-2031). He has authored 86 publications in top-tier journals, like Cell, Nature Genetics, and Nature Method, averaging ~45.5 citations per paper, and led the development of 14 software tools with over 250,000 downloads. His recognised expertise is demonstrated through 14 national/international awards, numerous invited talks (21 international, 42 national), invited grant reviews for funding bodies in nine countries, and active editorial roles for BMC Cancer and Genome Medicine. His commitment to propelling the field forward is evident in leading roles within key consortia and forums and his dedication to organise training workshops and conferences. He has secured over $31 million in grant funding as a chief investigator from national and international funding agencies (e.g., ARC, NHMRC, MRFF, DoD, NCI) and from industry partners, with approximately $11million directly supporting his lab's groundbreaking work.

Quan Nguyen
Quan Nguyen

Dr Wilbert Jesus Villena Gonzales

Research Fellow
School of Electrical Engineering and Computer Science
Faculty of Engineering, Architecture and Information Technology
Availability:
Available for supervision
Wilbert Jesus Villena Gonzales
Wilbert Jesus Villena Gonzales